We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Top Buys

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$72.6M
2
RNAM
Avidity Biosciences
RNAM
+$33.7M
3
CUTR
Cutera, Inc.
CUTR
+$31.5M
4
ACET icon
Adicet Bio
ACET
+$13M
5
RBAC
RedBall Acquisition Corp.
RBAC
+$12.4M

Top Sells

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$26.8M
2
PMVP icon
PMV Pharmaceuticals
PMVP
+$26.3M
3
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$16.9M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
GBTG icon
American Express Global Business Travel
GBTG
+$7.37M

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.67B
$7.95M 0.77%
+1,500,000
New +$9.07M
TARS icon
27
Tarsus Pharmaceuticals
TARS
$2.84B
$7.8M 0.75%
534,524
– –
XGN icon
28
Exagen
XGN
$166M
$7.78M 0.75%
1,355,414
-29,217
-2% -$170K
BNT
29
Brookfield Wealth Solutions
BNT
$12.2B
$7.07M 0.68%
237,719
+177,087
+292% +$5.88M
ALPAU
30
DELISTED
Alpha Healthcare Acquisition Corp III Units
ALPAU
$6.83M 0.66%
700,000
– –
FAZE
31
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$6.45M 0.62%
647,549
-283,473
-30% -$2.8M
ODP
32
DELISTED
ODP
ODP
$6.34M 0.61%
209,681
– –
SWCH
33
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$6.23M 0.6%
+186,100
New +$6.01M
BWAC
34
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$5.68M 0.55%
+550,000
New +$5.66M
BOAC
35
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$5.65M 0.55%
+569,891
New +$5.64M
HTZWW
36
Hertz Global Holdings Warrants
HTZWW
$95.5M
$5.33M 0.51%
544,069
-27,853
-5% -$360K
BENE
37
DELISTED
Benessere Capital Acquisition Corp. Class A Common Stock
BENE
$5.17M 0.5%
+500,000
New +$5.15M
MRNA icon
38
PUT
Moderna
MRNA
$23.6B
$5.04M 0.49%
16,300
– –
MSAC
39
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$4.9M 0.47%
500,000
– –
NOK icon
40
Nokia
NOK
$52.3B
$4.61M 0.45%
1,000,000
– –
BWAY
41
Brainsway
BWAY
$622M
$4.56M 0.44%
1,833,818
+135,400
+8% +$457K
MIC
42
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$4.47M 0.43%
1,143,142
+243,710
+27% +$921K
IMUX icon
43
Immunic
IMUX
$195M
$4.17M 0.4%
120,069
-5,646
-4% -$362K
MTAL
44
DELISTED
Metals Acquisition
MTAL
$4.07M 0.39%
+415,855
New +$4.11M
C icon
45
Citigroup
C
$226B
$3.32M 0.32%
72,188
+12,439
+21% +$622K
APGN
46
DELISTED
Apexigen, Inc. Common Stock
APGN
$3.05M 0.29%
+300,000
New +$3.04M
WBD icon
47
Warner Bros
WBD
$67.1B
$2.98M 0.29%
222,200
– –
BROS icon
48
Dutch Bros
BROS
$9.26B
$2.85M 0.28%
+90,000
New +$3.69M
SILJ icon
49
Amplify Junior Silver Miners ETF
SILJ
$3.85B
$2.75M 0.27%
288,971
-112,249
-28% -$1.34M
LMND icon
50
Lemonade
LMND
$4.1B
$2.74M 0.26%
150,000
+77,200
+106% +$1.63M
1
2
3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.